New depression pill shows early promise in clinical trial
NCT ID NCT06309277
Summary
This study tested an experimental oral medication called GM-1020 in people with moderate to severe depression. The main goals were to check if the drug is safe and well-tolerated, and to look for early signs that it might help reduce depression symptoms. The trial involved 46 adults and measured changes in depression scores over a short period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MAC Clinical Research
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.